Mass Spectrometry
Mass spectrometry (MS) - based proteomics allows the sensitive and accurate quantification of almost complete proteomes of complex biological fluids and tissues. At the moment, however, the routinely usage of MS-based proteomics is prevented and complicated by the very complex work flow comprising sample preparation, chromatography, MS measurement followed by data processing and evaluation. The new technologies, products and assays developed by Precision Proteomics could help enabling and establishing mass spectrometry (MS) - based proteomics in academic and pharmaceutical research as well as in clinical diagnostics.
Related Conference of Mass Spectrometry
Mass Spectrometry Conference Speakers
Recommended Sessions
- Glyco-Biomarkers
- Genomics
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycans in Genetic Disorders
- Glyco Immunology
- Glyco-Bioinformatics
- Glyco-proteomics
- Glycobiology
- Glycobiology and Biotechnology
- Glycobiology and Structural biology
- Glycobiology in Personalized Medicine
- Glycomics and Metabolomics
- Glycoprotein Technologies
- Mass Spectrometry
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
